Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brain Adaptations in Chronic Pain with Opioid Exposure
NCT05463367Phase 2Active, not recruiting
- Sponsor
- Northwestern University
- Start
- Jan 2021
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of carbidopa + levodopa in chronic back pain, opioid withdrawal, sponsored by Northwestern University. Started Jan 2021; status: active, not recruiting.
02
Drugs
carbidopa + levodopa
03
Conditions
chronic back painopioid withdrawal
Beyond the preview
Go deeper on NCT05463367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05463367.